Adventum has been acquired by Humana
Humana, a leading Swedish provider of personal assistance services, has acquired Adventum, a specialized care provider offering support and care for children with social and psychiatric problems. Financial terms of this transaction have not been disclosed.
Humana is focused on elderly care, individual and family care, residential arrangements offering support and services for persons with certain functional impairments, as well as schools for students with disabilities.
This acquisition is an important step for Humana in developing its business unit Individual and Family that includes Baggium Care and Treatment, Tian Group and K REHAB. Adventum is a fast-growing, high quality company in an exciting market that is in the initial consolidation phase.
Oaklins' team in Sweden advised the seller in this transaction.
Prata med transaktionsteamet
Relaterade transaktioner
MEDIK Hospital Design Group has been acquired by STERIS
The private shareholders of MEDIK Hospital Design Group have sold their shares to STERIS plc. Together, MEDIK and STERIS will expand their offerings for hospitals and ambulatory surgery centers worldwide. MEDIK’s solutions ideally complement STERIS’ existing portfolio, enabling the combined group to strengthen its position as a leading provider of turnkey room solutions in surgical and IPT environments. The MEDIK management team will actively support the next phase of growth.
Lär dig merbioXXmed AG has sold Rancoderm GmbH to Rose Investment- und Beteiligungs AG
Rancoderm GmbH has been acquired by Rose Investment- und Beteiligungs AG to secure the funding required for the final development and market approval of its medical device DermaPro. The acquisition will enable Rancoderm to bring DermaPro to market readiness and launch it as a certified medical product for broad distribution.
Lär dig merBanook, backed by Motion Equity, has acquired Fluidda
Banook Group has acquired Fluidda NV, marking a strategic expansion into advanced in-silico trials and respiratory disease modeling. Combining Banook’s expertise in cardiac safety and clinical data services with Fluidda’s AI-driven respiratory analytics creates a powerful, integrated platform. This deal strengthens Banook’s position in the contract research organization (CRO) sector, offering pharmaceutical clients broader, technology-enabled solutions to drive drug development and reduce costs.
Lär dig mer